From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Topics>
  3. Lipid Management>
  4. Archives

Lipid Management: Archives

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.

Items 1-25 of 197 are shown

Effect of Statins on Responses to Interferon Beta-1a

A retrospective study suggests that statins do not interfere with the therapeutic effects of IFNβ-1a in multiple sclerosis, but methodologic problems render the issue unresolved.

Refining Antiplatelet Treatment in Patients with Acute Coronary Syndromes

In a randomized trial, oral ticagrelor outperformed clopidogrel.

Statins to Prevent Perioperative Cardiovascular Events

In high-risk patients, several weeks of statin therapy before vascular surgery led to less ischemia and fewer MIs.

Combination Lipid-Lowering Therapy May Not Be More Effective Than High-Dose Statin Monotherapy

"Limited evidence" suggests that combination lipid-lowering therapy is no more effective than high-dose statin monotherapy for improving clinical outcomes, according to a meta...

Statin Reload Beneficial in Percutaneous Coronary Intervention

The ARMYDA-RECAPTURE results demonstrate that the protective effects of statin loading before PCI extend to ACS patients who are already taking statins.

Statins for Primary Prevention: Homing in on Effectiveness

A new meta-analysis bolsters the case for benefit.

Active Commuting and Cardiovascular Risk

Walking or biking to work is associated with some favorable risk markers, but whether these practices confer a benefit is unclear.

Childhood Socioeconomic Status and Inflammatory Disease

Deprivation in childhood increases markers of inflammation in adults, regardless of adult prosperity.

Statins for Primary Prevention of Cardiovascular Disease

Statin users were less likely to experience major adverse coronary or cerebrovascular events.

Red Yeast Rice for Hypercholesterolemia in People with Statin-Related Myalgias

This herbal supplement lowered LDL cholesterol levels without causing intolerable myalgias.

Medicare Part D, Prescription Drug Spending, and Total Medical Spending

In patients with little or no drug coverage before Part D enactment, additional drug costs during the program’s first 2 years were offset by reductions in other medical costs.

More Tofu, Please?

In a small randomized, controlled study, a low-carbohydrate, plant-based diet improved lipid measures more than a high-carbohydrate, low-fat diet.

An Herbal Option for Statin-Intolerant Patients?

A supplement of red yeast rice outperforms placebo in a small randomized trial.

Rapid Weight Gain in Early Infancy Increases Risk for Cardiovascular Disease and Diabetes

Infants with rapid weight gain had significantly greater body fat and waist circumference and reduced insulin sensitivity as adults, compared with infants with slow weight gain.

Prevention of Death After Stroke

Only a quarter of British stroke patients (age, ≥50) received recommended drug combinations.

U.S. Trends in Cardiovascular Disease and Diabetes, 1999 Through 2006

Although racial and socioeconomic disparities in disease control persist, insurance coverage appears to narrow the gaps.

Lipid Changes Differ Within HIV Drug Classes

In a pooled analysis of clinical trials, tenofovir-based therapies and those containing efavirenz or ritonavir-boosted atazanavir, darunavir, or saquinavir had the most favorable effects on plasma lipids.

Independent Effects of LDL Cholesterol and hsCRP Lowering in the JUPITER Trial

Greater hsCRP reductions correlated with improved cardiovascular outcomes.

Secondary Prevention of Cardiovascular Events in Daily Practice

A longitudinal analysis of cross-sectional study results reveals an urgent need for effective lifestyle management.

Statins and Venous Thrombosis

Recent studies confirm that statins lower risk for VT and suggest that the agents could aid in managing venous disease.

Do Statins Prevent Cardiovascular Events in Hemodialysis Patients?

Not according to findings from this randomized, controlled trial

TIPS for Reducing Cardiovascular Risk

In a large feasibility trial, one small pill had favorable effects on many important risk markers.

Statins to Prevent Venous Thromboembolic Disease

The beneficial effects of statins on arterial thrombosis and inflammation appear to extend to the venous side as well.

Hold the Statins

Even with the AAP’s updated guidelines for treating hyperlipidemia, few adolescents will meet criteria for pharmacologic management.

HDL Levels and Coronary Heart Disease: It’s Complicated

According to a meta-regression analysis, interventions that modify HDL levels do not reduce risk for CHD.

Items 1-25 of 197 are shown

Search

Advanced

Sign-In

Forgot your password?

New to Journal Watch?





Copyright © 2009. Massachusetts Medical Society. All rights reserved.